Powered by

Shire pays $5.2B for NPS Pharmaceuticals

Jan 11, 2015 - The Deal Pipeline

Irish pharmaceuticals company Shire plc on Sunday said it had agreed to pay about $5.2 billion for loss-making rare disease specialist NPS Pharmaceuticals Inc.(NPSP), striking its largest ever acquisition three months after erstwhile suitor AbbVie Inc. (ABBV) pulled a £32 billion ($48.5 billion) takeover agreement because of a U.S. clampdown on tax inversions.

Shire agreed to pay $46 per share for NPS, of Bedminster, N.J. The price is 9.8% more than NPS' $41.91 Friday closing price a...